Sprash Pharmaceutical Private Limited
About Sprash Pharmaceutical Private Limited
Data last updated:
Sprash Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2013PTC249883. Its GSTIN is 27AATCS9752K1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Parmeshwar Annasaheb Lambud (Managing Director) and Manisha Parmeshwar Lambud.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 302 3rd Floor Tirupati Gaurav Society Survey No. 416/2 Belapur, Thane, Maharashtra, India – 400614.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.17 Lakh. For the same year it recorded a net profit of ₹1.65 Lakh (net margin 12.5%) and EBITDA of ₹1.68 Lakh (EBITDA margin 12.8%). Revenue has declined at a compounded annual rate (CAGR) of 83% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sprash Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 302 3rd Floor Tirupati Gaurav Society Survey No. 416/2 Belapur, Thane, Maharashtra, India – 400614
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sprash Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sprash Pharmaceutical is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Sprash Pharmaceutical Private Limited, buy the company report.
Financials of Sprash Pharmaceutical Private Limited
FY 2024 filings availableSprash Pharmaceutical Private Limited reported revenue of ₹13.17 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years. EBITDA rose 505% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | ||||
| Net Profit Margin | 12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sprash Pharmaceutical Private Limited, buy the company report.
Board of directors of Sprash Pharmaceutical Private Limited
Sprash Pharmaceutical has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Parmeshwar Lambud Also directs: Giomed Lifesciences LLP | Director | 07 Nov 2013 | 12 Years 11 Months | Current |
| Radha Dattatray Walaskar | Director | 07 Nov 2013 | 12 Years 11 Months | Current |
| Parmeshwar Annasaheb Lambud | Managing Director | 07 Nov 2013 | 12 Years 11 Months | Current |
| Vijaya Vinod Lambud | Director | 07 Nov 2013 | 12 Years 11 Months | Current |
| Dattatraya Dnyanoba Walaskar | Director | 07 Nov 2013 | 12 Years 11 Months | Current |
Auditor
Sprash Pharmaceutical Private Limited is audited by SHRIKANTSURESHKOLI for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHRIKANTSURESHKOLI | FY 2024 | 175737 |
Shareholding
The shareholding of Sprash Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sprash Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sprash Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sprash Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sprash Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCS9752K1ZB | Maharashtra | Active | 13 Jul 2017 |
To see the full GST registrations and return filing status of Sprash Pharmaceutical Private Limited, buy the company report.
Recent activity
Sprash Pharmaceutical Private Limited has 5 board changes on record since 2013: 5 appointments. The latest: Dattatraya Dnyanoba Walaskar was appointed as Director on 07 Nov 2013.
Frequently asked questions
Sprash Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 November 2013 (13+ years old) and is registered under CIN U24233MH2013PTC249883.
Sprash Pharmaceutical has 5 current directors:
- Parmeshwar Annasaheb Lambud - Managing Director
- Manisha Parmeshwar Lambud - Director
- Radha Dattatray Walaskar - Director
- Vijaya Vinod Lambud - Director
- Dattatraya Dnyanoba Walaskar - Director
The latest financial statements of Sprash Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sprash Pharmaceutical is 27AATCS9752K1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sprash Pharmaceutical is U24233MH2013PTC249883. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sprash Pharmaceutical was incorporated on 07 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Dattatraya Dnyanoba Walaskar was appointed as Director on 07 Nov 2013. Manisha Parmeshwar Lambud was appointed as Director on 07 Nov 2013. Parmeshwar Annasaheb Lambud was appointed as Managing Director on 07 Nov 2013. Sprash Pharmaceutical has 5 board changes on record in total.
The registered office of Sprash Pharmaceutical is at Flat No. 302 3rd Floor Tirupati Gaurav Society Survey No. 4162 Belapur, Thane, Maharashtra, India – 400614.
Sprash Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sprash Pharmaceutical is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.